QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the third quarter and first nine months of 2024. Net sales rose 5% to $502 million in Q3 2024 over Q3 2023, while ...
With Netflix and Endeavor Deals Looming, TKO Reports Growth In Q3
With a pair of major deals on the horizon in early 2025, TKO Group Holdings continued to see year-over-year growth in its third-quarter earnings.